Search published articles


Showing 2 results for Abdulsalam

Richard Akele, Seyi Enitan, Esther Adejumo, Eyiuche Ezigbo, Abiodun Durosinmi, Grace Itodo, Adedeji Abdulsalam, Michael Dada, Okeoghene Edafetanure-Ibeh, Oyekan Oyedoyin, Polit Yelpoji, Abah Idoko, Ogunwola Opeyemi, Ogbuji Nmesomachi, Edwin Okafor, Adesola Oyekale,
Volume 9, Issue 1 (6-2022)
Abstract

Introduction: Vaccine hesitancy is a global phenomenon and vaccination efforts against the Coronavirus Disease 2019 (COVID-19) pandemic may be hampered by it. This study assessed the acceptance rate of COVID-19 vaccination at different hypothetical efficacy and safety levels in Nigeria. Methods: This web-based study was conducted among a selected Nigerian population between the month of February and May 2021 using an online self-administered structured questionnaire hosted by Survey Monkey. WhatsApp, Twitter and Facebook were used to disseminate the invitation to take the poll. Results: The finding of this study revealed that a larger proportion of the participants were males (53.9%), within the age group of 31-40 years (25.6%) and earn an average income of less than $500 per month. Individuals between the ages of 21 and 30 years and 31 to 40 years showed the highest levels of acceptability for the COVID-19 vaccine at 95% efficacy and 5% adverse effects. The older age group (>51 years and above) had the least vaccine acceptance rate (3.3%) at 75% vaccine efficacy and 20% side effect. Respondents who held the belief that vaccinations are essential for their health had a higher chance to accept the COVID-19 vaccine with OR: 0.76; 50%CI (0.00-0.00), OR:  95%CI (0.000-0.000), OR: 1.23; 95%CI (0.193-7.860) and OR: 0.696; 95%CI (0.048-10.047) based on religion, the occurrence of diabetes, pulmonary disease, and Hypertension, respectively. Conclusion: The results of this research indicate that vaccine acceptance rates are negatively correlated with participants' ages.
Seyi Enitan Samson, Abiodun Durosinmi, Richard Yomi Akele, Esther Ngozi Adejumo, Eyiuche Doris Ezigbo, Adesola Oyekunle Oyekale, Michael Olugbamila Dada, Okeoghene Marcel Edafetanure-Ibeh, Polit Umanka Yelpoji, Grace Eleojo Itodo, Ogbuji Sylvia Nmesomachi, Abah Michael Idoko, Edwin Nkemjika Okafor, Ogunwola Oluwatosin Opeyemi, Adedeji Abimbola Abdulsalam, Oyekan Ifeoluwa Oyedoyin,
Volume 9, Issue 1 (6-2022)
Abstract

Introduction: The coronavirus disease 2019 (COVID-19) is a vaccine-preventable disease amongst all ages; however, parental attitudes, perceptions and concerns towards children’s vaccination can hamper immunization efforts and leave this vulnerable group of the society unprotected. The aim of this study is to assess the attitude, perception and concern towards children’s vaccination amidst the COVID-19 Pandemic among selected workers in a Nigerian population. Methods: This web-based study was conducted among a selected Nigerian population between the month of February and May 2021 using an online self-administered structured questionnaire hosted by Survey Monkey. The invitation to take part in the poll was sent out to a total of 180 persons through social networking platforms including Facebook, Twitter, and WhatsApp. Version 25 of the Statistical Package for the Social Sciences (SPSS) was used to analyze the data collected and results presented using tables, bar charts and pie charts. The cutoff point was established at a level of significance equal to P < 0.05. Results: Vaccine hesitant score on childhood acceptance rates shows that 28 (15.6%) had low acceptance rates, 125 (69.4%) had moderate acceptance rates, and 27 (15.0%) had high acceptance rates. There was significant association between age and overall vaccine hesitance on children’s vaccination acceptance rates at χ2 = 16.804, P = 0.032. Conclusion: More than two-thirds of study participants supported children's vaccination. Those with low compliance may lack a realistic perception of infection risk, poor-quality information about immunizations and the disease, and general understanding.

Page 1 from 1     

© 2025 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.